Safety and tolerability of human mesenchymal stem cells for patients with decompensated cirrhosis

被引：0
|
作者：
Fu, Qingchun
Wang, Xiaojin
Luo, Zhaoxia
Ni, Liuda
Li, Li
Chen, Jinjin
Zhou, Feng
Shi, Liqin
Jin, Yinpeng
Lv, Guangxiu
Hu, Xiang
Chen, Chengwei
机构：
[1] Shanghai Liver Dis Res Ctr, Shanghai, Peoples R China
[2] Shenzhen Beike Cell Engn Res Inst, Shenzhen, Peoples R China
来源：
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY | 2013年 / 28卷
关键词：
stem cell; adverse event; cirrhosis; safety;
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：398 / 398
页数：1
相关论文
共 50 条
  • [1] SAFETY AND TOLERABILITY OF HUMAN MESENCHYMAL STEM CELLS FOR PATIENTS WITH DECOMPENSATED LIVER CIRRHOSIS: A PRELIMINARY STUDY
    Fu, Q.
    Jiang, S.
    Wang, X.
    Luo, Z.
    Ni, L.
    Ye, S.
    Zhou, F.
    Shi, L.
    Chen, J.
    Lv, G.
    Wang, Z.
    Chen, C.
    Hu, X.
    [J]. JOURNAL OF HEPATOLOGY, 2013, 58 : S35 - S36
  • [2] Decompensated Cirrhosis - Are mesenchymal Stem Cells a Therapeutic Option?
    Weiss, Johannes
    [J]. ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2014, 52 (03): : 254 - 254
  • [3] Human umbilical cord mesenchymal stem cells improve liver function and ascites in decompensated liver cirrhosis patients
    Zhang, Zheng
    Lin, Hu
    Shi, Ming
    Xu, Ruonan
    Fu, Junliang
    Lv, Jiyun
    Chen, Liming
    Lv, Sa
    Li, Yuanyuan
    Yu, Shuangjie
    Geng, Hua
    Jin, Lei
    Lau, George K. K.
    Wang, Fu-Sheng
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2012, 27 : 112 - 120
  • [4] SAFETY OF USE OF COMBINATION OF AUTOLOGOUS MESENCHYMAL AND HEMATOPOIETIC STEM CELL INFUSION IN DECOMPENSATED CIRRHOSIS
    Sharma, Mithun
    Rao, Padaki Nagaraja
    Kulkarni, Anand
    Kumar, Pramod
    Jagtap, Nitin
    Gupta, Rajesh
    Singh, Jagdeesh Rampal
    Mitnala, Sasikala
    Nageshwar, Duvurr
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2019, 34 : 55 - 55
  • [5] A case series on safety and tolerability of human umbilical cord-derived mesenchymal stem cells on patients in Malaysia
    Yusof, Basmullah
    Kamal, Iqmaliza
    Lee, Ka Man
    Chai, Siong Kiat
    Zuo, Xia Lin
    Ravichandran, Manickam
    Ding, Ke Xiang
    Fuloria, Neeraj Kumar
    Tham, Seng Kong
    [J]. SAGE OPEN MEDICAL CASE REPORTS, 2024, 12
  • [6] Immunomodulatory effect of bone marrow mesenchymal stem cells on T lymphocytes in patients with decompensated liver cirrhosis
    Guo, C. H.
    Han, L. X.
    Wan, M. R.
    Deng, G. J.
    Gan, J. H.
    [J]. GENETICS AND MOLECULAR RESEARCH, 2015, 14 (02) : 7039 - 7046
  • [7] Human Umbilical Cord Blood-Derived Mesenchymal Stem Cell Transplantation for Patients with Decompensated Liver Cirrhosis
    Zepeng Li
    Xiaoling Zhou
    Lu Han
    Meijie Shi
    Huanming Xiao
    Ming Lin
    Xiaoling Chi
    [J]. Journal of Gastrointestinal Surgery, 2023, 27 : 926 - 931
  • [8] Human umbilical cord mesenchymal stem cell treatment improves survival rate in patients with decompensated liver cirrhosis
    Shi, M.
    Li, Y.
    Xu, R.
    Meng, F.
    Wang, F. -S.
    [J]. JOURNAL OF HEPATOLOGY, 2017, 66 (01) : S558 - S559
  • [9] Human Umbilical Cord Blood-Derived Mesenchymal Stem Cell Transplantation for Patients with Decompensated Liver Cirrhosis
    Li, Zepeng
    Zhou, Xiaoling
    Han, Lu
    Shi, Meijie
    Xiao, Huanming
    Lin, Ming
    Chi, Xiaoling
    [J]. JOURNAL OF GASTROINTESTINAL SURGERY, 2023, 27 (05) : 926 - 931
  • [10] Phase II human trial of autologous mesenchymal stem cell transplantation for the treatment of decompensated cirrhosis
    Alimoghaddam, K.
    Mohamadnejad, M.
    Bagheri, M.
    Bashtar, M.
    Ghanati, H.
    Bonab, M. Mohyedin
    Ghavamzadeh, A.
    Malekzadeh, R.
    [J]. BONE MARROW TRANSPLANTATION, 2008, 41 : S318 - S319
12345